Articaine Hydrochloride Companies

Septodont Launched Septanest Forte (2% articaine with 1:100,000 epinephrine) in the US market, offering a potent option for pain management in dentistry.

Dentsply Sirona Introduced X-Guide dynamic navigation system, improving precision and efficiency in dental implant placement, potentially utilizing articaine for pain management.

Novocol Healthcare Expanded their presence in South Asia through strategic partnerships, aiming to increase articaine accessibility in growing dental markets.

Anhui BBCA Pharmaceutical Co., Ltd. Focused on research and development of high-quality articaine formulations for injectable and topical applications.

Pierrel SpA Received GMP certification for their new manufacturing facility, enhancing their production capacity for articaine hydrochloride.

• 3M (US)


• Anhui BBCA Pharmaceutical Co., Ltd. (China)


• Dentsply Sirona (US)


• Inibsa Dental S.L.U (Spain)


• Jinan Chenghui Shuangda Chemical Co., Ltd. (China)


• Jinan Ruixing Pharmaceutical Technology Co., Ltd (China)


• Manus Aktteva Biopharma LLP (India)


• Pfizer Inc. (US)


• Pierrel S.p.A (Italy)


• Sanofi (France)


• Septodont (France)


• Siegfried AG (Switzerland)


• Sigma Aldrich (US)